Metabolic cardiovascular risk profiles: a comparative study of khat-chewing and non-chewing women using hormonal contraception in Dhamar District, Yemen
DOI:
https://doi.org/10.18203/2320-6012.ijrms20260954Keywords:
Yemen, Cardiovascular risk, Hormonal contraception, KhatAbstract
Background: The concurrent use of khat (Catha edulis) and hormonal contraceptives (HC) is common among Yemeni women, yet its combined effect on novel metabolic cardiovascular risk markers is poorly understood. This study compared the impact of khat chewing on serum homocysteine (Hcy), c-reactive protein (CRP), the atherogenic index of plasma (AIP), and lipid profiles in HC.
Methods: A comparative cross-sectional study was conducted in Dhamar District, Yemen. One hundred women using HC were divided into 50 khat chewers and 50 non-chewers. Fasting blood samples were analyzed for Hcy, CRP, and lipid profiles, with calculation of AIP and (TC/HDL, LDL/HDL) ratios.
Results: Khat-chewing women exhibited a significantly more adverse metabolic profile. Key findings included elevated diastolic blood pressure (75.80±12.14 versus 68.40±11.13 mmHg, p=0.002), higher homocysteine (7.81±2.55 versus 6.77±2.53 µmol/l, p=0.04), elevated CRP (4.88±1.25 versus 4.26±1.32 mg/l, p=0.01), lower HDL-C (46.58±8.06 versus 49.96±8.35 mg/dl, p=0.04), higher triglycerides (159.99±41.44 versus 141.17±19.58 mg/dl, p=0.005), and a substantially higher AIP (0.38±0.12 versus 0.30±0.094, p<0.001). A dose-response relationship was observed, with heavy use linked to greater disturbances. A significant interaction was found between khat and contraceptive type on atherogenic ratios.
Conclusions: Among Yemeni women using hormonal contraception, khat chewing is a significant risk factor for an adverse cardiovascular profile, including hypertension, a pro-inflammatory and pro-thrombotic state, and atherogenic dyslipidemia. The harmful metabolic effects of khat were found to be modified by the type of contraceptive used. These effects also intensify with chewing duration, underscoring the critical need for targeted screening and personalized contraceptive counselling for khat-using women.
Metrics
References
Mehta LS, Velarde GP, Lewey J, Sharma G, Bond RM, Navas-Acien A, et al. Cardiovascular disease risk factors in women: the impact of race and ethnicity: a scientific statement from the American Heart Association. Circulation. 2023;147(19):1471-87. DOI: https://doi.org/10.1161/CIR.0000000000001139
Kasal DAB, De Lorenzo A. Oral contraceptives and cardiovascular risk: adding clinical evidence to the pathophysiology. Int J Cardiovasc Sci. 2020;33(3):215-6. DOI: https://doi.org/10.36660/ijcs.20200078
Tschiderer L, Seekircher L, Willeit P, Peters SAE. Assessment of cardiovascular risk in women: progress so far and progress to come. Int J Womens Health. 2023;15:191-212. DOI: https://doi.org/10.2147/IJWH.S364012
Crespo AB, Valle SG, Beltran DA, Iglesias AG. Effect of four hormonal contraceptives on lipid profile under real conditions of use after 6 months of treatment. Food Sci Nutr. 2020;6(3):1-7. DOI: https://doi.org/10.24966/FSN-1076/100065
Bastos Brito M, Brito MB, Nobre F, Sales Vieira C. Clinical update hormonal contraception and cardiovascular system. Arq Bras Cardiol. 2011;96(4):81-9. DOI: https://doi.org/10.1590/S0066-782X2011005000022
Al-Kebsi M. Angiographic characteristics of young Yemeni patients undergoing diagnostic coronary angiography: data from a major cardiac center in Yemen. Sana’a Univ J Med Health Sci. 2022;1(1):1-5. DOI: https://doi.org/10.59628/jchm.v1i1.87
Alsagheer NK, Abuhadi HA, Al Ansi AK, Ameen MA, Al-Radhy AA, Shujaa AM, et al. Acute coronary syndrome and Khat consumption in Yemeni women admitted to Coronary Care and Intensive Care in major hospital in Yemen. Sana’a Univ J Med Health Sci. 2024;18(4):73-9. DOI: https://doi.org/10.59628/jchm.v18i4.1180
Jayed D, Al-huthi MA, Al-zandani A, Al-shuki S. Spectrum of heart diseases in Sana’a, capital of Yemen Republic. Open Access Libr J. 2023;10(2333-9721):1-14. DOI: https://doi.org/10.4236/oalib.1109707
Al-Kebsi MM, Al-Motarreb A, Al-Wather N, Al-Tanobi A, Al-Fakih HA, Al-Dahbali A, et al. Characteristics and risk factors of yemeni patients presenting with myocardial infarction with nonobstructive coronary arteries (MINOCA). Hear Views. 2021;22(4):235-9. DOI: https://doi.org/10.4103/heartviews.heartviews_86_21
Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131(10):861-70. DOI: https://doi.org/10.1161/CIRCULATIONAHA.114.011201
WHO. Family Planning/Contraception Fact Sheet. World Health Organization. 2021.
Momeni Z, Dehghani A, Fallahzadeh H, Koohgardi M, Dafei M, Hekmatimoghaddam SH, et al. The impacts of pill contraceptive low-dose on plasma levels of nitric oxide, homocysteine, and lipid profiles in the exposed versus non exposed women: as the risk factor for cardiovascular diseases. Contracept Reprod Med. 2020;5(1):1-6. DOI: https://doi.org/10.1186/s40834-020-00110-z
Dima L, Moga M, Samotə I, Dracea L, Festila DG, Pascu A. C-reactive protein and homocysteine as predictors of cardiovascular risk associated to hormonal contraceptives use. Gineco.eu. 2015;11(4):199-202. DOI: https://doi.org/10.18643/gieu.2015.199
Conde‐Agudelo A, Rosas‐Bermudez A, Castaño F, Norton MH. Effects of birth spacing on maternal, perinatal, infant, and child health: a systematic review of causal mechanisms. Stud Fam Plann. 2012;43(2):93-114. DOI: https://doi.org/10.1111/j.1728-4465.2012.00308.x
Abdullahi HL, Muhammed L. Serum homocysteine level in hormonal contraceptive users in Kano Metropolis. Bayero J Med Lab Sci. 2020;5(2):64-8.
Sitruk-Ware R. Pharmacological profile of progestins. Maturitas. 2008;61(1-2):151-7. DOI: https://doi.org/10.1016/j.maturitas.2008.11.011
Alawdi SH. Metabolic Syndrome among a Sample of Women using Contraceptives. Clin J Pharmacol Pharmacother. 2018;1:1-4.
Al-Khaleq O, Mehrass A. Prevalence and predictors of oral contraceptive pills use among Yemeni Women in Dhamar Area. Am J Health Res. 2016;4(1):1. DOI: https://doi.org/10.11648/j.ajhr.20160401.11
Yemen MOPHP. Yemen National Health and Demographic Survey 2013 Ministry of Public Health and Population and Central Statistical Organization World Bank. 2015:1-385.
Ministry of Public Health and Population (Yemen) CSO. Yemen National Health and Demographic Survey 2013. 2014. Available from: https://dhsprogram.com/pubs/pdf/fr296/fr296.pdf. Accessed on 3 December 2025.
Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: a bench to bedside review. Thromb Res. 2020;192:40-51. DOI: https://doi.org/10.1016/j.thromres.2020.05.008
Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol. 2009;53(3):221-31. DOI: https://doi.org/10.1016/j.jacc.2008.09.042
Al-Juhaishi T, Al-Kindi S, Gehani A. Khat: a widely used drug of abuse in the horn of Africa and the Arabian Peninsula: review of literature. Qatar Med J. 2012;2012(2):1-6. DOI: https://doi.org/10.5339/qmj.2012.2.5
Khawaja M, Al-Nsour M, Saad G. Khat (Catha edulis) chewing during pregnancy in Yemen: findings from a national population survey. Matern Child Health J. 2008;12(3):308-12. DOI: https://doi.org/10.1007/s10995-007-0231-2
Nakajima M, Hoffman R, Al’Absi M. Level of khat dependence, use patterns, and psychosocial correlates in Yemen: a cross-sectional investigation. EMHJ. 2017;23(3):161-7. DOI: https://doi.org/10.26719/2017.23.3.161
Al-Motarreb A, Al-Kebsi M, Al-Adhi B, Broadley KJ. Khat chewing and acute myocardial infarction. Heart. 2002;87(3):279-80. DOI: https://doi.org/10.1136/heart.87.3.279
Hassan NAGM, Gunaid AA, Murray-Lyon IM. Khat (Catha edulis): health aspects of khat chewing. East Mediterr Health J, 2007;13:706.
Kastelein JJP, Van Der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008;117(23):3002-9. DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.713438
Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. Jama. 2007;298(7):776-85. DOI: https://doi.org/10.1001/jama.298.7.776
Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, Pérez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285-94. DOI: https://doi.org/10.1016/j.arcmed.2019.08.009
Dobiás̆ová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583-8. DOI: https://doi.org/10.1016/S0009-9120(01)00263-6
Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Panoulis CP, Kouskouni EE, et al. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma. J Cardiovasc Pharmacol. 2006;47(4):542-8. DOI: https://doi.org/10.1097/01.fjc.0000211747.16573.d5
Faeh D, Chiolero A, Paccaud F. Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about? Swiss Med Wkly. 2006;136(4748):745-56. DOI: https://doi.org/10.4414/smw.2006.11283
Toya T, Sara JD, Lerman B, Ahmad A, Taher R, Godo S, et al. Elevated plasma homocysteine levels are associated with impaired peripheral microvascular vasomotor response. Int J Cardiol Heart Vasc. 2020;8:100515. DOI: https://doi.org/10.1016/j.ijcha.2020.100515
Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 2004;11(1):S56-64. DOI: https://doi.org/10.1038/sj.cdd.4401451
Yuan D, Chu J, Lin H, Zhu G, Qian J, Yu Y, et al. Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis. Front Cardiovasc Med. 2023;9:1109445. DOI: https://doi.org/10.3389/fcvm.2022.1109445
Zou T, Yang W, Hou Z, Yang J. Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox. Acta Biochim Biophys Sin. 2010;42(12):908-15. DOI: https://doi.org/10.1093/abbs/gmq102
Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14(1):1-10. DOI: https://doi.org/10.1186/1475-2891-14-6
Pang X, Liu J, Zhao J, Mao J, Zhang X, Feng L, et al. Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells. Atherosclerosis. 2014;236(1):73-81. DOI: https://doi.org/10.1016/j.atherosclerosis.2014.06.021
Azzini E, Ruggeri S, Polito A. Homocysteine: its possible emerging role in at-risk population groups. Int J Mol Sci. 2020;21(4):1-27. DOI: https://doi.org/10.3390/ijms21041421
Downloads
Published
How to Cite
Issue
Section
